N/A
N=11
Magnetic Resonance Imaging Using Innovative Pulse Sequences
Clinical Indication for a Head MRI
Bottom Line
View on ClinicalTrials.gov: NCT01724216 ↗Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcome: Primary: Number of Head Images Successfully Collected — 10 Images
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- pulse sequences (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- GE Healthcare
- Primary completion
- Feb 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Head Images Successfully Collected |
10 | — |
Summary
The purpose of the study is to collect in vivo human image data to demonstrate neurological magnetic resonance imaging (MRI) of subjects using short pulse sequences.
Eligibility Criteria
Inclusion Criteria
- Subject must be at least 18 years of age
- Subject must be willing and able to undergo verbal and written informed consent
- Subject must have a clinical indication for a head MRI with and without Gadolinium-based contrast agent administration
Exclusion Criteria
- Subjects who have any of the conditions below at the time of the enrollment or scan session are excluded from this study. Further, should it be determined by study staff that an enrolled subject meets any of the conditions below during the course of the study, the subject will be removed from the study.
- Any contraindication to an MRI scan per the policy of Spectrum Health
- Any contraindication to administration of an MRI contrast agent per the policy of Spectrum Health
- Off-label utilization of contrast agents administered for the subject's clinical exam
Data sourced from ClinicalTrials.gov (NCT01724216). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.